• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ulcerative injection-site reaction associated with dupilumab therapy.

作者信息

Phan Michael, Linfante Anthony, Kroger Kathleen

机构信息

School of Medicine, The University of Texas Medical Branch, Galveston, Texas.

Department of Dermatology, The University of Texas Medical Branch, Galveston, Texas.

出版信息

JAAD Case Rep. 2020 Oct 8;6(12):1350-1352. doi: 10.1016/j.jdcr.2020.09.022. eCollection 2020 Dec.

DOI:10.1016/j.jdcr.2020.09.022
PMID:33912642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8064933/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d02e/8064933/723d14cbc400/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d02e/8064933/723d14cbc400/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d02e/8064933/723d14cbc400/gr1.jpg

相似文献

1
Ulcerative injection-site reaction associated with dupilumab therapy.与度普利尤单抗治疗相关的溃疡性注射部位反应。
JAAD Case Rep. 2020 Oct 8;6(12):1350-1352. doi: 10.1016/j.jdcr.2020.09.022. eCollection 2020 Dec.
2
Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: A meta-analysis.成人中重度特应性皮炎患者使用度普利尤单抗的不良反应：一项荟萃分析。
Int Immunopharmacol. 2018 Jan;54:303-310. doi: 10.1016/j.intimp.2017.11.031. Epub 2017 Nov 25.
3
A review of dupilumab in the treatment of atopic diseases.度普利尤单抗治疗特应性疾病的研究综述。
Hum Vaccin Immunother. 2019;15(9):2129-2139. doi: 10.1080/21645515.2019.1582403. Epub 2019 Mar 27.
4
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.度普利尤单抗联合外用皮质类固醇治疗中重度特应性皮炎的长期管理（LIBERTY AD CHRONOS）：一项为期 1 年、随机、双盲、安慰剂对照、3 期临床试验。
Lancet. 2017 Jun 10;389(10086):2287-2303. doi: 10.1016/S0140-6736(17)31191-1. Epub 2017 May 4.
5
Dupilumab side effect in a patient with atopic dermatitis: a case report study.度普利尤单抗在一名特应性皮炎患者中的副作用：一项病例报告研究。
Biologics. 2019 May 13;13:79-82. doi: 10.2147/BTT.S195512. eCollection 2019.
6
Dupilumab: A Review in Moderate-to-Severe Atopic Dermatitis.度普利尤单抗：中重度特应性皮炎治疗药物。
Am J Clin Dermatol. 2018 Aug;19(4):617-624. doi: 10.1007/s40257-018-0370-9.
7
Dupilumab: A review of its use in the treatment of atopic dermatitis.度普利尤单抗：治疗特应性皮炎的研究进展。
J Am Acad Dermatol. 2018 Mar;78(3 Suppl 1):S28-S36. doi: 10.1016/j.jaad.2017.12.022.
8
Dupilumab for Atopic Dermatitis: The Silver Bullet We Have Been Searching for?度普利尤单抗治疗特应性皮炎：我们一直在寻找的万灵药？
Cureus. 2020 Apr 6;12(4):e7565. doi: 10.7759/cureus.7565.
9
Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2).度普利尤单抗单药治疗中重度特应性皮炎成人患者的疗效和安全性：两项 3 期随机临床试验（LIBERTY AD SOLO 1 和 LIBERTY AD SOLO 2）的汇总分析。
J Dermatol Sci. 2019 May;94(2):266-275. doi: 10.1016/j.jdermsci.2019.02.002. Epub 2019 Mar 12.
10
Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).度普利尤单抗联合外用皮质类固醇治疗对环孢素 A 应答不足或不耐受或当这种治疗在医学上不建议时的中重度特应性皮炎成人患者：一项安慰剂对照、随机 III 期临床试验（LIBERTY AD CAFÉ）。
Br J Dermatol. 2018 May;178(5):1083-1101. doi: 10.1111/bjd.16156. Epub 2018 Mar 25.

引用本文的文献

1
Delayed Hyperpigmented Injection Site Reactions Due to Chronic Dupilumab Use.长期使用度普利尤单抗导致的延迟性注射部位色素沉着反应
Cureus. 2023 Apr 11;15(4):e37441. doi: 10.7759/cureus.37441. eCollection 2023 Apr.

本文引用的文献

1
Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2).度普利尤单抗单药治疗中重度特应性皮炎成人患者的疗效和安全性：两项 3 期随机临床试验（LIBERTY AD SOLO 1 和 LIBERTY AD SOLO 2）的汇总分析。
J Dermatol Sci. 2019 May;94(2):266-275. doi: 10.1016/j.jdermsci.2019.02.002. Epub 2019 Mar 12.
2
Injection site reactions with the use of biological agents.生物制剂使用中的注射部位反应。
Dermatol Ther. 2019 Mar;32(2):e12817. doi: 10.1111/dth.12817. Epub 2019 Jan 29.
3
Are Injection Site Reactions in Monoclonal Antibody Therapies Caused by Polysorbate Excipient Degradants?
单克隆抗体治疗中的注射部位反应是由聚山梨酯赋形剂降解产物引起的吗？
J Pharm Sci. 2018 Nov;107(11):2735-2741. doi: 10.1016/j.xphs.2018.07.016. Epub 2018 Jul 25.
4
Injection Site Necrosis and Ulceration Following Vaccination in an Adult Patient.一名成年患者接种疫苗后出现注射部位坏死和溃疡
J Drugs Dermatol. 2018 Mar 1;17(3):364-367.
5
Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis.度普利尤单抗：基于证据对其治疗特应性皮炎潜力的综述
Core Evid. 2018 Feb 23;13:13-20. doi: 10.2147/CE.S133661. eCollection 2018.
6
Injection Site Reactions to Biologic Agents Used in Psoriasis and Psoriatic Arthritis.银屑病和银屑病关节炎中生物制剂的注射部位反应
J Drugs Dermatol. 2017 Jul 1;16(7):695-698.
7
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.度普利尤单抗联合外用皮质类固醇治疗中重度特应性皮炎的长期管理（LIBERTY AD CHRONOS）：一项为期 1 年、随机、双盲、安慰剂对照、3 期临床试验。
Lancet. 2017 Jun 10;389(10086):2287-2303. doi: 10.1016/S0140-6736(17)31191-1. Epub 2017 May 4.
8
Dupilumab in persistent asthma with elevated eosinophil levels.度普利尤单抗治疗嗜酸性粒细胞水平升高的持续性哮喘。
N Engl J Med. 2013 Jun 27;368(26):2455-66. doi: 10.1056/NEJMoa1304048. Epub 2013 May 21.
9
Ulcerative skin reaction from subcutaneous infusion of isotonic methotrimeprazine and diamorphine.皮下输注等渗甲硫哒嗪和二醋吗啡引起的溃疡性皮肤反应。
Clin Oncol (R Coll Radiol). 1995;7(4):268-9. doi: 10.1016/s0936-6555(05)80619-3.